BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center for Biomedical System Design - ECPv5.16.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Center for Biomedical System Design
X-ORIGINAL-URL:https://newdigs.tuftsmedicalcenter.org
X-WR-CALDESC:Events for Center for Biomedical System Design
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200623
DTEND;VALUE=DATE:20200624
DTSTAMP:20260407T083924
CREATED:20220608T222611Z
LAST-MODIFIED:20220608T222705Z
UID:1719-1592870400-1592956799@newdigs.tuftsmedicalcenter.org
SUMMARY:FierceBiotech VIRTUAL SERIES: CLINICAL TRIALS
DESCRIPTION:In their hunt for new approvals\, biopharma companies spend billions of dollars every year on clinical trials. In recent years\, though\, real-world studies as sources of practice-informing data––and even as the basis for new indications––have multiplied. but clinical trials remain the gold standard. \nIn a post-pandemic future\, will clinical trials ever look the same again? Could real-world data help fill in the gaps? In this session\, we will discuss the role real-world evidence now plays in informing clinical guidelines and securing new indications for approved medicines. We will also consider the novel coronavirus’ effect on the traditional clinical trial model and how real-world evidence could evolve as an important tool for drugmakers and regulators as research adapts to a new reality.
URL:https://newdigs.tuftsmedicalcenter.org/event/fiercebiotech-virtual-series-clinical-trials/
LOCATION:Online\, MD
CATEGORIES:Speaking Engagement
END:VEVENT
END:VCALENDAR